Genovis AB (publ.) Future Growth
Future criteria checks 3/6
Genovis AB (publ.) is forecast to grow earnings and revenue by 14.9% and 20.2% per annum respectively. EPS is expected to grow by 26.1% per annum. Return on equity is forecast to be 17.5% in 3 years.
Key information
14.9%
Earnings growth rate
26.1%
EPS growth rate
Life Sciences earnings growth | 46.3% |
Revenue growth rate | 20.2% |
Future return on equity | 17.5% |
Analyst coverage | Low |
Last updated | 20 Aug 2024 |
Recent future growth updates
Recent updates
The Genovis AB (publ.) (STO:GENO) Analysts Have Been Trimming Their Sales Forecasts
Aug 21Is Now The Time To Look At Buying Genovis AB (publ.) (STO:GENO)?
Aug 12Genovis AB (publ.)'s (STO:GENO) 36% Jump Shows Its Popularity With Investors
May 31This Is Why Genovis AB (publ.)'s (STO:GENO) CEO Compensation Looks Appropriate
May 09Genovis AB (publ.) Just Missed Earnings - But Analysts Have Updated Their Models
Apr 26Is Now The Time To Look At Buying Genovis AB (publ.) (STO:GENO)?
Mar 18What You Can Learn From Genovis AB (publ.)'s (STO:GENO) P/EAfter Its 25% Share Price Crash
Feb 28We Think That There Are Issues Underlying Genovis AB (publ.)'s (STO:GENO) Earnings
Feb 22These Analysts Just Made A Huge Downgrade To Their Genovis AB (publ.) (STO:GENO) EPS Forecasts
Feb 20Genovis AB (publ.) (STO:GENO) Analysts Are More Bearish Than They Used To Be
Feb 04Here's Why Genovis AB (publ.) (STO:GENO) Has Caught The Eye Of Investors
Oct 06Are Genovis AB (publ.) (STO:GENO) Investors Paying Above The Intrinsic Value?
Jun 22What Does Genovis AB (publ.)'s (STO:GENO) Share Price Indicate?
May 13Do Genovis AB (publ.)'s (STO:GENO) Earnings Warrant Your Attention?
Dec 22Should You Think About Buying Genovis AB (publ.) (STO:GENO) Now?
Nov 14If EPS Growth Is Important To You, Genovis AB (publ.) (STO:GENO) Presents An Opportunity
Jul 08Is There An Opportunity With Genovis AB (publ.)'s (STO:GENO) 43% Undervaluation?
Jun 01Genovis AB (publ.)'s (STO:GENO) Popularity With Investors Under Threat As Stock Sinks 27%
May 10One Analyst Just Shaved Their Genovis AB (publ.) (STO:GENO) Forecasts Dramatically
Feb 10Is Now The Time To Put Genovis AB (publ.) (STO:GENO) On Your Watchlist?
Aug 09What Is Genovis AB (publ.)'s (STO:GENO) Share Price Doing?
Mar 27How Does Genovis AB (publ.)'s (STO:GENO) CEO Pay Compare With Company Performance?
Dec 30Is Now An Opportune Moment To Examine Genovis AB (publ.) (STO:GENO)?
Nov 23Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 214 | 43 | 39 | 53 | 3 |
12/31/2025 | 180 | 48 | 44 | 57 | 3 |
12/31/2024 | 132 | 35 | 29 | 43 | 2 |
3/31/2024 | 128 | 31 | 27 | 39 | N/A |
12/31/2023 | 159 | 62 | 55 | 68 | N/A |
9/30/2023 | 158 | 54 | 40 | 53 | N/A |
6/30/2023 | 151 | 57 | 40 | 49 | N/A |
3/31/2023 | 142 | 42 | 42 | 47 | N/A |
12/31/2022 | 104 | 11 | -5 | -1 | N/A |
9/30/2022 | 119 | 41 | 40 | 43 | N/A |
6/30/2022 | 112 | 36 | 40 | 43 | N/A |
3/31/2022 | 111 | 36 | 37 | 41 | N/A |
12/31/2021 | 94 | 25 | 41 | 46 | N/A |
9/30/2021 | 71 | 11 | 3 | 6 | N/A |
6/30/2021 | 69 | 12 | 1 | 7 | N/A |
3/31/2021 | 65 | 9 | -12 | 9 | N/A |
12/31/2020 | 61 | 6 | -17 | 4 | N/A |
9/30/2020 | 54 | -3 | -16 | 7 | N/A |
6/30/2020 | 64 | 3 | -11 | 9 | N/A |
3/31/2020 | 60 | 6 | 4 | 9 | N/A |
12/31/2019 | 61 | 10 | 8 | 13 | N/A |
9/30/2019 | 58 | 12 | 7 | 10 | N/A |
6/30/2019 | 43 | 5 | 0 | 4 | N/A |
3/31/2019 | 40 | 1 | 2 | 3 | N/A |
12/31/2018 | 35 | -2 | -3 | -1 | N/A |
9/30/2018 | 31 | -4 | -4 | -2 | N/A |
6/30/2018 | 27 | -6 | -6 | -5 | N/A |
3/31/2018 | 24 | -7 | -10 | -9 | N/A |
12/31/2017 | 23 | -8 | N/A | -8 | N/A |
9/30/2017 | 21 | -9 | N/A | -9 | N/A |
6/30/2017 | 21 | -9 | N/A | -11 | N/A |
3/31/2017 | 20 | -14 | N/A | -15 | N/A |
12/31/2016 | 19 | -15 | N/A | -16 | N/A |
9/30/2016 | 17 | -16 | N/A | -18 | N/A |
6/30/2016 | 16 | -21 | N/A | -18 | N/A |
3/31/2016 | 14 | -18 | N/A | -14 | N/A |
12/31/2015 | 14 | -20 | N/A | -16 | N/A |
9/30/2015 | 13 | -25 | N/A | -18 | N/A |
6/30/2015 | 11 | -24 | N/A | -20 | N/A |
3/31/2015 | 10 | -23 | N/A | -21 | N/A |
12/31/2014 | 10 | -22 | N/A | -22 | N/A |
9/30/2014 | 8 | -20 | N/A | -18 | N/A |
6/30/2014 | 10 | -17 | N/A | -17 | N/A |
3/31/2014 | 11 | -16 | N/A | -14 | N/A |
12/31/2013 | 10 | -16 | N/A | -12 | N/A |
9/30/2013 | 10 | -19 | N/A | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GENO's forecast earnings growth (14.9% per year) is above the savings rate (1.1%).
Earnings vs Market: GENO's earnings (14.9% per year) are forecast to grow slower than the Swedish market (16% per year).
High Growth Earnings: GENO's earnings are forecast to grow, but not significantly.
Revenue vs Market: GENO's revenue (20.2% per year) is forecast to grow faster than the Swedish market (1% per year).
High Growth Revenue: GENO's revenue (20.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GENO's Return on Equity is forecast to be low in 3 years time (17.5%).